IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Emory University

Q1 2015 Holdings

Filed 2015-05-15 | 10 holdings | $3.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$1.2M9,71539.0%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$957.0K29,35630.8%
Biocryst Pharmaceuticals(BCRX)COM09058V103$886.0K98,16128.5%
Vanguard Intl Equity Index F(VWO)FTSE EMR MKT ETF922042858$43.3K1,058,7811.4%
Anacor Pharmaceuticals IncCOM032420101$1.3K23,3250.0%
Incyte Corp(INCY)COM45337C102$1.2K12,7290.0%
Bellicum Pharmaceuticals IncCOM079481107$1.0K45,2610.0%
Seattle Genetics IncCOM812578102$1.0K29,5350.0%
Genomic Health Inc(GHDX)COM37244C101$98332,1670.0%
Synageva Biopharma CorpCOM87159A103$9619,8540.0%